This site uses cookies to store information on your computer. Learn more x

Share Buy-Back Programs 2018

Repurchase of 1,100,000 shares totals €98.9 million (Aug - Oct 2018)

DSM repurchased a total of 1,100,000 shares for a combined consideration of €98.9 million in accordance with the repurchase program to cover commitments under share-based compensation plans and stock dividend which ran between 13 August and 5 October 2018.

In accordance with regulations DSM informed the market about the progress made in the execution of this program through weekly press releases whilst the buy-back program was ongoing.

See also the ‘Daily transaction details 1.1m Share Repurchase Program announced 13 Aug 2018’ below, which was updated weekly during the course of the buy-back program.

Repurchase of 1,600,000 shares totals €136.7 million (Mar - Apr & May – Jun 2018)

DSM repurchased a total of 1,600,000 shares for a combined consideration of €136.7 million in accordance with the repurchase program to cover share-based compensation plans and stock dividend which ran between 19 March to 11 April and 14 May to 20 June 2018.

In accordance with the regulations, DSM informed the market about the progress made in the execution of this program through weekly press releases whilst the buy-back program was ongoing.

See also the ‘Daily transaction details 1.6m Share Repurchase Program announced 19 Mar 2018’ below, which was updated weekly during the course of the buy-back program.

Statement pursuant to art. 5:25a of the Dutch Financial Supervision Act
DSM also announces that The Netherlands is its "Home Member State", as required by article 5:25a (2) of the Dutch Financial Supervision Act. This article obliges all listed companies to publicly announce which country is their "home member state" (as referred to in article 5:25a(1) sub c of the Dutch Financial Supervision Act) for purposes of regulation of their disclosure obligations under the EU Transparency Directive. Pursuant to section 5:25a of the Dutch Financial Supervision Act Royal DSM has notified the Autoriteit Financiële Markten (AFM).